MedTrace Logo

The Study of Antidepressant Properties and Safety of Fer-01(Soline®) on the Patients With Depression

NCT01671124 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2012-09-11

No results posted yet for this study

Summary

Considering the potential modulatory effects of Salvia divinorum, Lycium, Chenpi and Dihuang supplementation on mood, this study is a clinical study of Soline® (product mixed with Salvia divinorum, Lycium, Chenpi and Dihuang ) supplementation to investigate the effect of attenuating the occurrence of depression. The study will enroll 100 patients who meet the inclusion and exclusion criteria. The trial will be concluded when a total of evaluable 80 patients (40 patients in each treatment group).

Conditions

Interventions

OTHER

Soline capsule

Sponsors & Collaborators

  • Taipei Medical University Shuang Ho Hospital

    collaborator OTHER

  • Taipei Medical University Hospital

    lead OTHER

Principal Investigators

  • Shih-Yi Huang, Ph.D · Taipei Medical University

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-07-31
Completion
2013-11-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01671124 on ClinicalTrials.gov